Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

NCT03254108 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Congestive Heart Failure

Interventions

DRUG: OPC-61815 injection 2mg
DRUG: OPC-61815 injection 4mg
DRUG: OPC-61815 injection 8mg
DRUG: OPC-61815 injection 16mg
DRUG: Tolvaptan tablet 15mg

Sponsor

Otsuka Pharmaceutical Co., Ltd.